Re: [Nautilus-list] HOT NEW BIOTECH COMPANY IN BARRONS THIS WEEK!!

[elijah wright <elw stderr org>]

could somebody get this spam off of the nautilus list, please?

thanks :)

~elijah

On Fri, 29 Sep 2000 HotStocks aba com wrote:

> Date: Fri, 29 Sep 2000 01:47:16
> From: HotStocks aba com
> To: nautilus-list lists eazel com
> Subject: [Nautilus-list] HOT NEW  BIOTECH COMPANY IN BARRONS THIS WEEK!!
> 
> Text version below:
> 
>  Dnaprint (DNAP) is an emerging biotech company in this weeks Barrons.
> 
> 
> 1) CEO (Dr. Tony Frudakis) Lead scientist for Corixa starts his own
> company a few months ago
> 
> 2) Company is formed by a reverse merger of a pinksheet company
> 
> 3) DNAP has already completed the accounting to get off the pinksheets
> and should be listed on the OTCBB soon.
> 
> 4) Dr. Frudakis was responsible for a patent that sold for $54,000,000 to
> Smith Kline Beecham while he was at Corixa.
> 
> 5) Corixa's stock has gone from 14 Cents a few years ago to 50 Dollars
> today.
> 
> 6) According to the Barron's article, Dnaprint is in the late stages of
> forming strategic alliances with major companies.
> 
> 7) DNAP is trading at 23.5 cents as of Friday's close !!!!!!!!!!!!!!!
> 
>  This is not from a registered financial advisory, please consult with a
> registered investment advisor before making an investment decision. This
> communication (print or electronic) reflects our opinions and does not
> necessarily reflect those of anyone else related to the firm and may be
> in conflict with the views or official views of the companies mentioned.
> Readers are advised that this publication (print or electronic) is issued
> solely for informational purposes and is not to be construed as an offer
> to sell or the solicitation of an offer to buy. This communication is
> based on information available to the public. We are NOT a professional
> advisory service, broker, investment firm or agency. We are NOT a stock
> picking service. The securities profiled here are solely of our own
> opinion and it is not recommended that you buy, sell, or hold based on
> what you find here. Please continue to perform your own Due Diligence. 
> Any investment decisions you make should be your own predicated upon your
> own findings and judgments born from your own research. All images and
> logo's used to represent DNAPrint are registered trademarks of DNAPrint.
> Barrons is a registered trademark of Dow Jones & Co., Inc..
>   
> 
> TEXT Version: Dnaprint (DNAP) is an emerging biotech company in this
> weeks Barrons. 1) CEO (Dr. Tony Frudakis) Lead scientist for Corixa
> starts his own company a few months ago 2) Company is formed by a reverse
> merger of a pinksheet company 3) DNAP has already completed the
> accounting to get off the pinksheets and should be listed on the OTCBB
> soon. 4) Dr. Frudakis was responsible for a patent that sold for
> $54,000,000 to Smith Kline Beecham while he was at Corixa. 5) Corixa's
> stock has gone from 14 Cents a few years ago to 50 Dollars today. 6)
> According to the Barron's article, Dnaprint is in the late stages of
> forming strategic alliances with major companies. 7) Dnap is trading at
> 23.5 cents at Friday's close !!!!
> _______________________________________________ Nautilus-list mailing
> list Nautilus-list lists eazel com
> http://www.eazel.com/mailman/listinfo/nautilus-list
> 

-- 





----
Do not seek to follow in the footsteps of the wise. Seek what they sought.
				- Basho, seventeenth century Japanese poet